CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Development and validation of a radiomics-based method for macrovascular invasion prediction in hepatocellular carcinoma with prognostic implication 会议论文
美国圣地亚哥, 2019年2月20日
作者:  Wei Jingwei;  Fu Sirui;  Zhang Shuaitong;  Zhang Jie;  Gu Dongsheng
收藏  |  浏览/下载：73/0  |  提交时间：2019/05/08
Deep Learning Based Classification for Metastasis of Hepatocellular Carcinoma with Microscopic Images 会议论文
San Diego, USA, 2019.2.16-2019.2.21
作者:  Meng, Hui;  Gao, Yuan;  Wang, Kun;  Tian, Jie
收藏  |  浏览/下载：6/0  |  提交时间：2020/04/29
Phase II trial of tepotinib vs sorafenib for treatment-naive advanced hepatocellular carcinoma (HCC) in Asian patients 会议论文
作者:  Ryoo, B-Y.;  Ren, Z.;  Kim, T-Y.;  Pan, H.;  Rau, K-M.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment 会议论文
作者:  Qin, S. K.;  Ren, Z. G.;  Meng, Z. Q.;  Chen, Z. D.;  Chai, X. L.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment 会议论文
作者:  Qin, S. K.;  Ren, Z. G.;  Meng, Z. Q.;  Chen, Z. D.;  Chai, X. L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/11/19
A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment 会议论文
ANNALS OF ONCOLOGY, 2018-10-01
作者:  Qin, S. K.;  Ren, Z. G.;  Meng, Z. Q.;  Chen, Z. D.;  Chai, X. L.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Texture analysis of hepatocellular carcinomas in Contrast-enhanced MR images for malignancy differentiation 会议论文
ISMRM 24th Annual Meeting & Exhibition, 新加坡
作者:  Wu Zhou;  Kaixin Wang;  Lijuan Zhang;  Guangyi Wang;  Zaiyi Liu
收藏  |  浏览/下载：17/0  |  提交时间：2017/01/15
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction 会议论文
作者:  Marrero, Jorge A.;  Lencioni, Riccardo;  Ye, Sheng-Long;  Kudo, Masatoshi;  Bronowicki, Jean-Pierre
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA [HCC] AND OF ITS TREATMENT WITH SORAFENIB [SOR]) 2ND INTERIM ANALYSIS (IA): SUBGROUP ANALYSIS BY DISEASE ETIOLOGY 会议论文
作者:  Bronowicki, J.;  Ye, S.;  Kudo, M.;  Marrero, J.;  Venook, A.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
SECOND INTERIM ANALYSIS OF GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN UNRESECTABLE HCC [UHCC] AND OF ITS TREATMENT WITH SORAFENIB): MULTIREGIONAL VARIATION IN PATIENT (PT) CHARACTERISTICS, PREVIOUS TREATMENT HISTORY, AND SORAFENIB (SOR) USE 会议论文
作者:  Kudo, Masatoshi;  Ye, Sheng-Long;  Venook, Alan;  Marrero, Jorge A.;  Nakajima, Keiko
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace